315 related articles for article (PubMed ID: 11960982)
21. Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
Teschemacher AG; Seward EP; Hancox JC; Witchel HJ
Br J Pharmacol; 1999 Sep; 128(2):479-85. PubMed ID: 10510461
[TBL] [Abstract][Full Text] [Related]
22. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
[TBL] [Abstract][Full Text] [Related]
23. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole.
Zhou Z; Vorperian VR; Gong Q; Zhang S; January CT
J Cardiovasc Electrophysiol; 1999 Jun; 10(6):836-43. PubMed ID: 10376921
[TBL] [Abstract][Full Text] [Related]
24. Dynamic control of deactivation gating by a soluble amino-terminal domain in HERG K(+) channels.
Wang J; Myers CD; Robertson GA
J Gen Physiol; 2000 Jun; 115(6):749-58. PubMed ID: 10828248
[TBL] [Abstract][Full Text] [Related]
25. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
Kang J; Chen XL; Wang L; Rampe D
J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
[TBL] [Abstract][Full Text] [Related]
26. Specific block of cloned Herg channels by clofilium and its tertiary analog LY97241.
Suessbrich H; Schönherr R; Heinemann SH; Lang F; Busch AE
FEBS Lett; 1997 Sep; 414(2):435-8. PubMed ID: 9315735
[TBL] [Abstract][Full Text] [Related]
27. State-dependent barium block of wild-type and inactivation-deficient HERG channels in Xenopus oocytes.
Weerapura M; Nattel S; Courtemanche M; Doern D; Ethier N; Hebert T
J Physiol; 2000 Jul; 526 Pt 2(Pt 2):265-78. PubMed ID: 10896755
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of azimilide and ambasilide on the human ether-a-go-go-related gene (HERG) potassium channel.
Walker BD; Singleton CB; Tie H; Bursill JA; Wyse KR; Valenzuela SM; Breit SN; Campbell TJ
Cardiovasc Res; 2000 Oct; 48(1):44-58. PubMed ID: 11033107
[TBL] [Abstract][Full Text] [Related]
29. Physicochemical features of the HERG channel drug binding site.
Fernandez D; Ghanta A; Kauffman GW; Sanguinetti MC
J Biol Chem; 2004 Mar; 279(11):10120-7. PubMed ID: 14699101
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channels.
Kiehn J; Thomas D; Karle CA; Schöls W; Kübler W
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):212-9. PubMed ID: 10208308
[TBL] [Abstract][Full Text] [Related]
31. Human ether-à-go-go-related gene K+ channel gating probed with extracellular ca2+. Evidence for two distinct voltage sensors.
Johnson JP; Mullins FM; Bennett PB
J Gen Physiol; 1999 Apr; 113(4):565-80. PubMed ID: 10102937
[TBL] [Abstract][Full Text] [Related]
32. Testosterone-mediated modulation of HERG blockade by proarrhythmic agents.
Shuba YM; Degtiar VE; Osipenko VN; Naidenov VG; Woosley RL
Biochem Pharmacol; 2001 Jul; 62(1):41-9. PubMed ID: 11377395
[TBL] [Abstract][Full Text] [Related]
33. Mutations of the S4-S5 linker alter activation properties of HERG potassium channels expressed in Xenopus oocytes.
Sanguinetti MC; Xu QP
J Physiol; 1999 Feb; 514 ( Pt 3)(Pt 3):667-75. PubMed ID: 9882738
[TBL] [Abstract][Full Text] [Related]
34. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
[TBL] [Abstract][Full Text] [Related]
35. Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: stereoselective bupivacaine block.
González T; Arias C; Caballero R; Moreno I; Delpón E; Tamargo J; Valenzuela C
Br J Pharmacol; 2002 Dec; 137(8):1269-79. PubMed ID: 12466236
[TBL] [Abstract][Full Text] [Related]
36. Blockade of HERG channels expressed in Xenopus oocytes by external H+.
Jo SH; Youm JB; Kim I; Lee CO; Earm YE; Ho WK
Pflugers Arch; 1999 Jun; 438(1):23-9. PubMed ID: 10370083
[TBL] [Abstract][Full Text] [Related]
37. Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate.
Mitcheson JS; Chen J; Sanguinetti MC
J Gen Physiol; 2000 Mar; 115(3):229-40. PubMed ID: 10694252
[TBL] [Abstract][Full Text] [Related]
38. BeKm-1 is a HERG-specific toxin that shares the structure with ChTx but the mechanism of action with ErgTx1.
Zhang M; Korolkova YV; Liu J; Jiang M; Grishin EV; Tseng GN
Biophys J; 2003 May; 84(5):3022-36. PubMed ID: 12719233
[TBL] [Abstract][Full Text] [Related]
39. Deletion of protein kinase A phosphorylation sites in the HERG potassium channel inhibits activation shift by protein kinase A.
Thomas D; Zhang W; Karle CA; Kathöfer S; Schöls W; Kübler W; Kiehn J
J Biol Chem; 1999 Sep; 274(39):27457-62. PubMed ID: 10488078
[TBL] [Abstract][Full Text] [Related]
40. Effects of Na+ channel blocker, pilsicainide, on HERG current expressed in HEK-293 cells.
Wu LM; Orikabe M; Hirano Y; Kawano S; Hiraoka M
J Cardiovasc Pharmacol; 2003 Sep; 42(3):410-8. PubMed ID: 12960687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
